etomoxir has been researched along with Prostatic Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilar, E; Balcells, C; Cascante, M; Dallmann, G; Marín de Mas, I; Marin, S; Papp, B; Thomson, TM; Zodda, E | 1 |
Cimic, A; Cramer, SD; Eckel, RH; Gijón, MA; Glodé, LM; Pac, CT; Rider, L; Rodrigues, LU; Romero, L; Schlaepfer, IR; Sirintrapun, SJ | 1 |
Agarwal, R; Boyle, KE; Cramer, SD; Deep, G; Eckel, RH; Glodé, LM; Hitz, CA; Lucia, SM; Maroni, P; Pac, CT; Schlaepfer, IR; Serkova, NJ | 1 |
3 other study(ies) available for etomoxir and Prostatic Neoplasms
Article | Year |
---|---|
Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells.
Topics: Arachidonic Acid; Biological Transport, Active; Cell Line, Tumor; Cell Proliferation; Computational Biology; Docosahexaenoic Acids; Eicosanoids; Epithelial-Mesenchymal Transition; Epoxy Compounds; Fatty Acids; Humans; Male; Metabolic Networks and Pathways; Mitochondria; Models, Biological; Neoplasm Invasiveness; Prostatic Neoplasms; Transcriptome | 2018 |
Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Enzyme Inhibitors; Epoxy Compounds; Humans; Hypoglycemic Agents; Lactones; Lipid Metabolism; Male; Metabolism; Mice; Mice, Nude; Orlistat; Oxidation-Reduction; Prostatic Neoplasms; Random Allocation; Signal Transduction; Xenograft Model Antitumor Assays | 2014 |
Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts.
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Epoxy Compounds; Fluorodeoxyglucose F18; Glucose; Heterografts; Humans; Hypoglycemic Agents; Lipid Metabolism; Male; Mice; Mice, Nude; Oxidation-Reduction; Positron-Emission Tomography; Prostatic Neoplasms | 2015 |